FREE PROMEGA WEBINAR
Date : 6thOctober 2022
Time : 11 am (Indonesia)
otency assays are an essential aspect of analyses of biotherapeutics, including CAR-T therapeutics. The potency assay format that will be used as a release assay for CT (in a QC environment) needs to be as accurate, precise and robust as possible. Developing a robust potency assay for CART therapeutics can be a long and complicated process. The mechanism of action of CAR-T cells – dubbed ‘living drugs* – in-vivo is multi-faceted.
Currently, target-cell killing and cytokine induction are two of the more prominent measures indicative of CAR-T potency in the cell therapy field. This webinar will provide the rationale and data that supports transitioning from current interpolation-based cytokine induction assays, with minimal number of dilutions (one), to full-curve analyses based upon MOA-reflective cellular responses.
In this webinar, you will lean more about :
• Limitations of existing CAR-T potency measurement approaches
• A new HiBiT target-cell killing based approach for CAR-T potency assessment
Link Webinar: https://bit.ly/3CnYcu5
Media mikrobiologi adalah tulang punggung setiap laboratorium yang terlibat dalam studi atau aplikasi mikroorganisme. Fungsi…
Indolab Utama menghadirkan penawaran spesial akhir tahun!Dapatkan diskon hingga 50% untuk berbagai produk laboratorium pilihan.…
Seiring meningkatnya volume sampel, terutama dalam studi genetik skala besar (genomik) dan uji diagnostik klinis…
Indolab Utama baru saja menyelesaikan training seru Isolasi DNA menggunakan kit A1120 di UMMADA Cirebon!…
Kami bangga menjalin kolaborasi dengan RSUD Koja dalam meningkatkan layanan patologi mereka. Indolab Utama telah…
Fenomena bioluminescence, yaitu produksi cahaya oleh organisme hidup melalui reaksi kimia, telah lama memukau manusia…